1. Home
  2. Live Updates
  3. Isoldem bergmann

Live Breaking News & Updates on Isoldem bergmann

Equine Sarcoids - visible success with delNS-based immunotherapy leads the way towards cancer therapy in humans

/PRNewswire/ Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids.

Vienna , Wien , Austria , Thomas-muster , Edmund-hainisch , Bluesky-immunotherapies-gmb , Bluesky-immunotherapies , Sabine-brandt , Isoldem-bergmann , Bluesky-immunotherapies-gmbh-ltd , University-of-veterinary-medicine-vienna , Veterinary-medicine-vienna

BlueSky Immunotherapies GmbH: Equine Sarcoids - visible success with delNS-based immunotherapy leads the way towards cancer therapy in humans

VIENNA, Dec. 10, 2021 /PRNewswire/ Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids in horses.

Vienna , Wien , Austria , Kostenloser-wertpapierhandel , Thomas-muster , Edmund-hainisch , Bluesky-immunotherapies-gmb , Bluesky-immunotherapies , Sabine-brandt , Isoldem-bergmann , Bluesky-immunotherapies-gmbh-ltd , University-of-veterinary-medicine-vienna

Equine Sarcoids - visible success with delNS-based immunotherapy leads the way towards cancer therapy in humans

/PRNewswire/ Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids.

Vienna , Wien , Austria , Thomas-muster , Edmund-hainisch , Bluesky-immunotherapies-gmb , Bluesky-immunotherapies , Sabine-brandt , Isoldem-bergmann , Bluesky-immunotherapies-gmbh-ltd , University-of-veterinary-medicine-vienna , Veterinary-medicine-vienna